Bibliography
- ADCOCK IM, ITO K: Molecular mechanisms of corticosteroid actions. Monaldi Arch. Chest Dis. (2000) 55(3):256–266.
- HUMBERT M: Ciclesonide: a novel inhaled corticosteroid. Expert Opin. Investig. Drugs (2004) 13(10):1349–1360
- •Review of the therapeutic profile of cidesonide.
- BIGGADIKE K, ANGELL RM, BURGESS CM et al.: Selective plasma hydrolysis of glucocorticoid y-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism. J. Med. Chem. (2000) 43(1):19–21.
- PROCOPIOU PA, BIGGADIKE K, ENGLISH AF et al.: Novel glucocorticoid antedrugs possessing a 170-(y-lactone) ring. J. Med. Chem. (2001) 44:4(602–612).
- NO AUTHORS LISTED: New steroids and steroid-longacting 132 agonist combinations. Expert Opin. Ther. Patents (2003) 13(4):557–561.
- ALI A, THOMPSON CF, BALKOVEC JM et al.: Novel N-arylpyrazolo [3,2-c] -based ligands for the glucocorticoid receptor: receptor binding and in vivo activity. J. Med. Chem. (2004) 47(10):2441–2452.
- KYM PR, KORT ME, COGHLAN MJ et al.: Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-ally1-2,5-dihydro-2,2,4-trimethy1-1H- [1] benzopyrano [3,4-fiquinolines. J. Med. Chem. (2003) 46(6):1016–1030.
- SCHAKE H, SCHOTTELIUS A. DOCKE WD et al.: Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc. NatL Acad. Sci. USA (2004) 101(1):227–232.
- RAY KP, FARROW S, DALY M et aL Induction of the E-selectin promoter by IL-1 and TNFa and inhibition by glucocorticoids. Biochem. J. (1997) 51:707–715.